International Psoriasis Council
Menu
Advancing Knowledge. Enhancing Care.
Menu
Symposia Recordings
In effort to bring valuable information and education to a wider audience, the IPC develops webcasts of the symposia taking place at important congresses throughout the year that can be accessed at any time.
UPDATES AND CHALLENGING CASES IN PSORIASIS: A FOCUS ON BIOMARKERS AND GPP
2022 RADLA VIRTUAL
Español
- Biomarcadores de Psoriasis: Predicción de la Respuesta | Catherine Smith, MD | United Kingdom
- Actualización en Psoriasis Pustular Generalizada | Johann Gudjonsson, MD, PhD | United States
- Caso Desafiante 1 | Fernando Valenzuela, MD | Chile
- Caso Desafiante 2 | Matias Maskin, MD | Argentina
- Caso Desafiante 3 | Ricardo Romiti, MD, PhD | Brazil
- 2022 RADLA Symposium | Panel de Discusión
Português
- Biomarcadores da Psoríase: Prevendo a Resposta | Catherine Smith, MD | United Kingdom
- Atualização em Psoríase Pustulosa Generalizada | Johann Gudjonsson, MD, PhD | United States
- Caso Desafiador 1 | Fernando Valenzuela, MD | Chile
- Caso Desafiador 2 | Matias Maskin, MD | Argentina
- Caso Desafiador 3 | Ricardo Romiti, MD, PhD | Brazil
- 2022 RADLA Symposium | Painel de Discussão
GETTING REAL (WORLD) WITH PSORIASIS: ADVANCES IN REGISTRIES AND REAL-WORLD DATA IN PSORIASIS
2022 SID
- Introduction to IPC & Real-World Data in Psoriasis | Joel Gelfand, MD, MSCE | United States
- Real-World Data Using Medical and Administrative Records | April Armstrong, MD, MPH | United States
- Real-World Data and Psoriasis: A European Perspective | Nick Reynolds, BSc, MBBS, MD, FRCP | United Kingdom
- Registries and Psoriasis: An Industry Perspective | Steven Fakharzadeh, MD, PhD | United States
- Innovations in Real-World Data | Alexis Ogdie, MD, MSCE | United States
- Panel Discussion | All faculty
Poster Presentations
- Your Pores and the Outdoors: Investigating the Association between Pollution and Inflammatory Dermatological Diseases | Manan Mehta, BS | United States
- Understanding Health Disparities among Patients with Psoriasis: Results from National Psoriasis Foundation Annual Surveys 2019 – 2021 | George Gondo, MA | United States
- Psoriasis Resolution in Challenging Body Areas with Lxekizumab: Response Trajectories by Patient Profile Clusters Over Time | Andrew Blauvelt, MD, MBA | United States
- The Patient Perspective on Vaccine Uptake in Adults with Psoriasis and Eczema | Megan H. Noe, MD, MPH, MSCE | United States
- Kullback-Leibler Divergence Model to Integrate Genetic and Genomic Information to Assess Drug Response for Psoriatic Patients | Qinmengge Li, BS, MS | United States
- HDL Composition, Particle Number and Size is Associated with Non-Calcified Coronary Plaque in Psoriasis | Álvaro Gonzales-Cantero, MD, PhD | Spain
- A Novel Expression Based, Non-Invasive Method to Differentiate Atopic Dermatitis and Psoriasis | Michael D Howell, PhD | United States
HOT TOPICS IN PSORIASIS: A FOCUS ON TREATMENT INNOVATIONS
2022 AAD
INTERNATIONAL PSORIASIS COUNCIL: SPECIAL POPULATIONS OF PATIENTS WITH PSORIASIS
2021 EADV Virtual
- Treating Women with Psoriasis | Mahira Hamdy El Sayed, MSc, MD | Egypt
- Pustular Psoriasis, Distinct Disease or Part of Psoriasis Spectrum? | Hervé Bachelez, PhD | France
- Challenging Case: A Patient with Psoriasis and Cancer | Lluís Puig, MD, PhD | Spain
- Personalized Care in Psoriatic Arthritis | Joseph Merola, MD, MMSc | United States
RESEARCH ON SARS-COV-2 DURING THE COVID-19 PANDEMIC CRISIS: AN IPC TRIBUTE TO YOUNG RESEARCHERS
2021 ESDR Virtual
- Autoantibodies to Type I IFNs in Patient with Life-Threatening COVID-19 | Paul Bastard, MD | France
- B-Cell Responses to SARS-CoV-2 in the Setting of COVID-19 Infection & Vaccination | Zijun Wang, PhD | United States
- COVID-19 and Psoriasis: Lessons from Real-Life Registries | Satveer Mahil, PhD | United Kingdom
- Interactions between Skin Inflammatory Diseases & COVID: Lessons from Genomic Epidemiology Studies| Matthew Patrick, MEng, PhD | United States
THE INTERNATIONAL PSORIASIS COUNCIL UPDATE ON THE LATEST RESEARCH
2021 IFPA Virtual
CHALLENGING CASES IN PSORIASIS: A FOCUS ON COVID-19, BIOLOGICS AND ADVERSE EVENTS
2021 RADLA Virtual
- COVID-19 and Psoriasis | Peter van de Kerkhof, MD, PhD | Netherlands
- Challenging Case: Linfoma Después del Tratamiento Biológico: ¿Qué fue primero? | Angela Londoño, MD | Colombia
- Challenging Case: Paradoxical Psoriasis Induced by Anti-TNF | Romina Contreras, MD | Paraguay
- Challenging Case: To Be or Not to Be? It is Not Always Psoriasis. | Fernando Valenzuela, MD | Chile
- Challenging Case: Eventos Adversos Cutáneos Durante La Terapia Biológica. | André Vicente Esteves de Carvalho, MD, PhD | Brazil
- Faculty Discussion | All faculty
HOT TOPICS AND CHALLENGING CASES IN PSORIASIS: A FOCUS ON COVID-19 AND SYSTEMIC/BIOLOGIC TREATMENT
2020 EADV Virtual
- An Elderly Patient with Severe Psoriasis – Which Treatment to Consider | Peter van de Kerkhof, MD, PhD | Netherlands
- Challenging case: How to Switch to the Most Optimal Treatment | Craig Leonardi, MD | USA
- Challenging case: Patient at Risk for Developing Severe Case COVID-19 | Lluis Puig, MD, PhD | Spain
- Choosing the MostAppropriate First Line Biologic | Richard Warren, BSc, MBChB, FRCP, PhD | UK
- How to Select a Systemic Treatment for Your Patient | Craig Leonardi, MD | USA